Lung immune prognostic index as a prognostic factor in patients with small cell lung cancer

Abstract Background The lung immune prognostic index (LIPI) is a marker that combines the derived neutrophil‐to‐lymphocyte ratio (dNLR) and serum lactate dehydrogenase (LDH) level and is a recently reported prognostic factor of immune checkpoint inhibitor therapy for non‐small cell lung cancer (NSCL...

Full description

Bibliographic Details
Main Authors: Kei Sonehara, Kazunari Tateishi, Masamichi Komatsu, Hiroshi Yamamoto, Masayuki Hanaoka
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:Thoracic Cancer
Subjects:
Online Access:https://doi.org/10.1111/1759-7714.13432